A person walks past the Pfizer Headquarters building in New York, December 7, 2020.
Carlo Allegri | Reuters
The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.
Editor's note: Graphic content. The following article contains photos of civilian casualties/injured children. Search teams and emergency aid from around...
U.S. stock index futures were muted and mixed Tuesday ahead of comments from Federal Reserve Chair Jerome Powell, speaking for...
Fed's Powell Talks Again Today. Listen to His Speech Closely. | Barron's Federal Reserve chair Jerome Powell is set to...
by Calculated Risk on 2/07/2023 08:00:00 AM Notes: This CoreLogic House Price Index report is for December. The recent Case-Shiller...
by Calculated Risk on 2/07/2023 08:40:00 AM From the Department of Commerce reported: The U.S. Census Bureau and the U.S....
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
